← Retour au Screener

Sector: Santé
Open in Terminal → CNCLive chart · Key metrics · News · Smart money

Centene Corporation

CNC Large Cap

Healthcare · Healthcare Plans

Mis à jour: Jun 18, 2026, 22:21 UTC

53,23 €
+0.59% aujourd'hui
52W: 21,89 € – 58,08 €
52W Low: 21,89 € Position: 86.6% 52W High: 58,08 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
13.69x
P/E prévisionnel
P/S Ratio
0.17x
Cours/Ventes
EV/EBITDA
7.93x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
26,3 Md €
Capitalisation boursière
Croissance du CA
5.1%
Croissance du CA sur un an
Marge bénéficiaire
-3.61%
Marge nette
ROE
-26.04%
Rentabilité des capitaux propres
Beta
1.09
Sensibilité au marché
Positions vendeuses
3.4%
% du flottant vendu à découvert
Volume moyen
6,178,165
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
17 analysts
Avg. Price Target
53,54 €
+0.58% upside
Target Range
34,91 € – 69,81 €

About the Company

Sector: Healthcare Industry: Healthcare Plans Country: United States Employees: 61,000 Exchange: NYQ

Centene Corporation en bref

Centene Corporation (CNC) is currently trading at 53,23 € with a market capitalization of 26,3 Md €. The 52-week range spans from 21,89 € to 58,08 €; the current price is 8.3% below the yearly high. Year-over-year revenue growth stands at +5.1%.

💰 Dividende

Centene Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

17 analystes évaluent Centene Corporation (CNC) au consensus : Acheter. L'objectif de cours moyen est de 53,54 €, soit un potentiel de +0.58% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 34,91 € à 69,81 €.

Centene Corporation : la thèse d'investissement en détail

Centene Corporation (CNC) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Valorisation en contexte

The PEG ratio at 1.18 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 7.93x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

Thèse d'investissement : forces et faiblesses

Points forts
  • Consensus des analystes : Buy
  • Free cash flow positif
Points faibles
  • Actuellement non rentable

Aperçu technique

MM 50 jours
46,49 €
+14.51% vs. cours
MM 200 jours
36,56 €
+45.62% vs. cours
Sous le plus haut 52s
−8.3%
58,08 €
Au-dessus du plus bas 52s
+143.2%
21,89 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.09 · Proche du marché
Évolue plus que le marché global
Positions vendeuses
3.4% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
76.05 · Modéré
Dette totale / capitaux propres

The data points to market-like volatility.

Trading Data

50-Day MA: 46,49 €
200-Day MA: 36,56 €
Volume: 3,900,588
Avg. Volume: 6,178,165
Short Ratio: 2.36
P/B Ratio: 1.41x
Debt/Equity: 76.05x
Free Cash Flow: 6,0 Md €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Centene Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut